✦ LIBER ✦

Biparietal diameter and crown-rump length in fetuses with Down's syndrome: implications for antenatal serum screening for Down's syndrome

✍ Scribed by Professor N. J. Wald; Mr D. Smith; Ms A. Kennard; Mr G. E. Palomaki; Dr R. Salonen; Professor W. Holzgreve; Dr B. Pejtsik; Dr E. J. Coombes; Dr G. Mancini; Dr A. R. MacRae; Dr P. Wyatt; Dr J. Roberson

Book ID: 111156072
Publisher: John Wiley and Sons
Year: 1993
Tongue: English
Weight: 483 KB
Volume: 100
Category: Article
ISSN: 1470-0328
DOI: 10.1111/j.1471-0528.1993.tb15267.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Serum markers for Down's syndrome in wom

Serum markers for Down's syndrome in women who have had in vitro fertilisation: implications for antenatal screening

✍ N. J. Wald; N. White; J. K. Morris; W. J. Huttly; J. A. Canick 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 270 KB

Repeat maternal serum alpha-fetoprotein

Repeat maternal serum alpha-fetoprotein testing in antenatal screening programmes for Down's syndrome

✍ HOWARD S. CUCKLE; NICHOLAS J. WALD; KIRAN NANCHAHAL; JAMES DENSEM 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 496 KB

MATERNAL SERUM INHIBIN-A LEVELS IN TWIN

MATERNAL SERUM INHIBIN-A LEVELS IN TWIN PREGNANCIES: IMPLICATIONS FOR SCREENING FOR DOWN'S SYNDROME

✍ H. C. WATT; N. J. WALD; L. GEORGE 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 197 KB 👁 3 views

A nested case-control study using stored serum samples collected as part of a prospective study of the outcome of pregnancy was performed to investigate concentrations of (dimeric) inhibin-A in maternal serum between 15 and 22 weeks of pregnancy in 200 twin pregnancies and 600 singleton control preg

MATERNAL SERUM INHIBIN-A IN PREGNANCIES

MATERNAL SERUM INHIBIN-A IN PREGNANCIES WITH INSULIN-DEPENDENT DIABETES MELLITUS: IMPLICATIONS FOR SCREENING FOR DOWN'S SYNDROME

✍ N. J. WALD; H. C. WATT; L. GEORGE 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 335 KB 👁 3 views

A nested case-control study using stored serum samples collected as part of a prospective study of the outcome of pregnancy was performed to investigate concentrations of (dimeric) inhibin-A in maternal serum between 15 and 22 weeks of pregnancy in 126 pregnancies among 92 women with insulin-depende

Maternal serum unconjugated oestriol and

Maternal serum unconjugated oestriol and human chorionic gonadotrophin levels in twin pregnancies: implications for screening for Down's syndrome

✍ NICHOLAS WALD; HOWARD CUCKLE; TIESHENG WU; LYNNE GEORGE 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 231 KB

COMBINING INHIBIN A WITH EXISTING SECOND

COMBINING INHIBIN A WITH EXISTING SECOND-TRIMESTER MARKERS IN MATERNAL SERUM SCREENING FOR DOWN'S SYNDROME

✍ H. S. CUCKLE; S. HOLDING; R. JONES; N. P. GROOME; E. M. WALLACE 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 444 KB 👁 3 views

To assess the value of inhibin A as an additional second-trimester maternal serum marker of Down's syndrome we studied 56 affected and 280 unaffected pregnancies matched for gestational age. The median level in the cases was 1.62 multiples of the gestation-specific median (MOM) in the controls, with